Clinical Trial Update: Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome

View source ↗

Summary

The clinical trial evaluating defective atypical PKC activation in diabetes mellitus, type 2, and metabolic syndrome has completed, with results posted in 2016.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Snippet

Sponsor: VA Office of Research and Development | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2016-05-19